-
Morgan Stanley Equal-Weight on MAKO Surgical
Thursday, November 10, 2011 - 8:51am | 99Morgan Stanley is out with a research report on MAKO Surgical (NASDAQ: MAKO) and it has an Equal-Weight rating on shares. In a note to clients, Morgan Stanley writes, "In a healthcare environment characterized by weak utilization, MAKO delivered a solid quarter and increased the low end of...
-
JP Morgan Raises PT on Mako Surgical to $37
Thursday, November 10, 2011 - 7:21am | 27JP Morgan has raised the price target on Make Surgical (NASDAQ: MAKO) from $28 to $37 and maintains its Neutral rating.
-
Disclosure Insight Maintains Medium Risk Rating on MAKO Surgical
Friday, October 28, 2011 - 7:00am | 81A report from D.I. reiterates its Medium Risk – Positive Bias rating on MAKO Surgical (NASDAQ: MAKO). The report states, “Insider ownership; related party transactions; and the chairman and CEO positions being held by one person support our opinion of a Medium Risk - Positive Bias rating on MAKO....
-
Morgan Keegan Lowers PT on Masimo to $27
Wednesday, October 26, 2011 - 8:12am | 27Morgan Keegan has lowered the price target on Masimo Corporation (NASDAQ: MASI) from $31 to $27 and maintains its Outperform rating.
-
Piper Jaffray Maintains Overweight Rating on Masimo
Wednesday, October 26, 2011 - 7:45am | 52According to Piper Jaffray, Masimo (NASDAQ: MASI) Overweight rating is maintained. Piper Jaffray said that Masimo reported disappointing 3Q11 results, with performance falling short of Street expectations. “We remain Overweight due to the 12-month potential with a $31 price target (was $36).”...
-
Zimmer Holdings Earnings Preview: Analysts Expect Higher EPS, Revenue
Tuesday, October 25, 2011 - 5:01pm | 561Zimmer Holdings (NYSE: ZMH) releases its next round of earnings this Thursday, October 27, 2011. Here's Benzinga's advanced look at Zimmer Holdings' third quarter earnings report. Earnings and Revenue: Wall Street expects an EPS of $1.03/share and revenues of $1.03 billion. Zimmer Holdings'...
-
Guangdong Biolight Meditech Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology
Monday, October 24, 2011 - 1:09pm | 94Masimo (NASDAQ: MASI) and Biolight today jointly announced both a worldwide technology licensing agreement and the launch of Masimo rainbow® SET Pulse CO-Oximetry technology in Biolight's new generation of modular patient monitors. The agreement allows Biolight to incorporate the breakthrough...
-
Blueshift Ideas Discusses MAKO Surgical
Thursday, October 20, 2011 - 1:42pm | 172Blueshift Ideas is out with a series of tweets on MAKO Surgical Corp. (NASDAQ: MAKO) and the joint replacement industry. Blueshift noted that MAKO Surgical needs clinical results, and a hip application in order to gain more market share. There are anywhere between four hundred and six hundred...
-
Piper Jaffray Maintains Overweight on Masimo
Monday, October 17, 2011 - 9:09am | 66Piper Jaffray is out with its report today on Masimo (NASDAQ: MASI), maintaining Overweight. In its report, Piper Jaffray writes, "We remain positive on Masimo's 12-month prospects, but believe shares may remain range-bound for the next two quarters until the trajectory of Rainbow adoption becomes...
-
Masimo Launches the 2011 Radical-7 with rainbow® Acoustic Monitoring and In Vivo Adjustment
Thursday, October 13, 2011 - 4:24pm | 84Masimo (NASDAQ: MASI) announced today FDA 510(k) clearance and CE Mark of its new Radical-7® with rainbow® Acoustic Monitoring capability for continuous display of the acoustic respiration rate (RRa™) waveform and measurements. Also new to the Radical-7 is an In Vivo Adjustment™ (pending FDA 510(k...
-
Goldman Sachs Removes MAKO Surgical from CL-Buy List, Raises PT To $44
Thursday, September 22, 2011 - 7:26am | 35Goldman Sachs has removed MAKO Surgical (NASDAQ: MAKO) from the Americas Conviction Buy List but maintains its Buy rating and has raised the price target from $37 to $44.
-
Monday's NASDAQ Winners: General Finance, SkyPeople Fruit Juice, MAKO Surgical, Optimer Pharmaceuticals
Tuesday, September 20, 2011 - 12:21pm | 422POINT ROBERTS - September 20, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Friday September 19th. Nasdaq closed lower, but off day's low and slid 9.48 (-0.36%) to 2,612.83. General Finance...
-
Mad Money Lightning Round: Cramer Likes Alcoa, Coach
Monday, September 12, 2011 - 3:56am | 247On CNBC's Mad Money, Jim Cramer said during the Lightning Round that Insituform Technologies (NASDAQ: INSU) “never seems to work. I don't want you to buy it. It's too risky." For MAKO Surgical (NASDAQ: MAKO), he said, "I think you ring the register and take half off the table. This is a dicey...
-
Stocks Hitting 52-Week Highs
Wednesday, September 7, 2011 - 9:57am | 147Pharmasset Inc (NASDAQ: VRUS) shares jumped 3.49% to create a new 52-week high of $72.99. Pharmasset announced 91% SVR12 from its phase 2b PROTON study in subjects with hepatitis C virus (HCV) genotype 1. Perfumania Holdings Inc (NASDAQ: PERF) shares gained 1.51% to touch a new 52-week high of $16...
-
NeuroMetrix Announces One-for-Six Reverse Stock Split
Thursday, September 1, 2011 - 4:01pm | 57NeuroMetrix, Inc. (Nasdaq: NURO) today announced the effectiveness of a one-for-six reverse stock split of its common stock. The reverse stock split, which was previously approved by the Company's shareholders at the 2011 Annual Meeting of Stockholders held on May 16, 2011, was approved by the...